Device Week, 19 August 2021 – Big FDA Approvals For Abbott, Zimmer Biomet

In this week’s podcast, Medtech Insight's US Commercial manager Reed Miller provides an overview of Abbott’s Amplatzer Amulet, which was approved by the US FDA for preventing thrombus embolization in patients with nonvalvular atrial fibrillation. Managing editor Marion Webb discusses Zimmer Biomet’s FDA clearance of its Rosa robotic surgery platform for total hip replacement and the intensifying competition in the rising surgical robotics market. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR